Significant spread of extensively drug-resistant Acinetobacter baumannii genotypes of clonal complex 92 among intensive care unit patients in a university hospital in southern Iran

Journal of Medical Microbiology

Volumn 66, Issue 11, 2017, Pages 1656-1662

  Saffari, Fereshteh ^a   Monsen, Tor ^b   Karmostaji, Afsaneh ^c   Azimabad, Fahimeh Bahadori ^c   Widerström, Micael ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UMEÅ UNIVERSITY   (Sweden)

^c HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; Cross infection; ICU; Iran; MLST; MLVA; Molecular epidemiology; Nosocomial infections; PFGE

Indexed keywords

AMIKACIN; BACTERIAL DNA; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CLUSTER ANALYSIS; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; GENOTYPE; GENOTYPING TECHNIQUE; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INTEGRON; INTENSIVE CARE UNIT; IRAN; MALE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; MULTILOCUS VARIABLE NUMBER TANDEM REPEAT ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; UNIVERSITY HOSPITAL; VARIABLE NUMBER OF TANDEM REPEAT; CROSS INFECTION; DRUG EFFECTS; GENETICS; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; IRAN; MALE;

EID: 85033366061     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000619     Document Type: Article

References (38)

1. Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B et al. Clinical and pathophysiological overview of acinetobacter infections: a century of challenges. Clin Microbiol Rev 2017;30: 409–447.
2. Karah N, Dwibedi CK, Sjöström K, Edquist P, Johansson A et al. Novel aminoglycoside resistance transposons and transposonderived circular forms detected in carbapenem-resistant Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 2016;60:1801–1818.
3. Lemos EV, de La Hoz FP, Einarson TR, McGhan WF, Quevedo E et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and metaanalysis. Clin Microbiol Infect 2014;20:416–423.
4. Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A et al. Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin Microbiol Rev 2017; 30:1–22.
5. WHO. 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed. Available from www.who.int/mediacentre/ news/releases/2017/bacteria-antibiotics-needed/en/.
6. Huang LY, Chen TL, Lu PL, Tsai CA, Cho WL et al. Dissemination of multidrug-resistant, class 1 integron-carrying Acinetobacter baumannii isolates in Taiwan. Clin Microbiol Infect 2008;14:1010–1019.
7. Ou HY, Kuang SN, He X, Molgora BM, Ewing PJ et al. Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors. Sci Rep 2015;5:8643.
8. Sirichot S, Diraphat P, Utrarachkij F, Tribuddharat C, Siripanichgon K. Dissemination of class I integron in Acinetobacter baumliannii isolated from ventilator-associated pneumonia patients and their environment. Southeast Asian J Trop Med Public Health 2009;40:1284–1292.
9. Wang H, Guo P, Sun H, Wang H, Yang Q et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 2007; 51:4022–4028.
10. Scaife W, Young HK, Paton RH, Amyes SG. Transferable imipenem- resistance in Acinetobacter species from a clinical source. J Antimicrob Chemother 1995;36:585–586.
11. Evans BA, Amyes SG. OXA beta-lactamases. Clinical microbiology reviews 2014;27:241–263.
12. Tomaschek F, Higgins PG, Stefanik D, Wisplinghoff H, Seifert H. Head-to-head comparison of two multi-locus sequence typing (MLST) schemes for characterization of Acinetobacter baumannii outbreak and sporadic isolates. PLoS One 2016;11:e0153014.
13. Pourcel C, Minandri F, Hauck Y, D’Arezzo S, Imperi F et al. Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J Clin Microbiol 2011;49:539–548.
14. Hojabri Z, Pajand O, Bonura C, Aleo A, Giammanco A et al. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J Antimicrob Chemother 2014;69:2383–2387.
15. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010;5:e10034.
16. Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B, Esmaeili D et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol 2015;6:1146.
17. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010;65:233–238.
18. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011;35:736–755.
19. Mencacci A, Monari C, Leli C, Merlini L, de Carolis E et al. Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2013;51:603–606.
20. CLSI. Performance standards for antimicrobial disk susceptibility tests, 9th ed Approved standard M02-A10. Wayne, PA: CLSI; 2012.
21. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–281.
22. Dillon B, Thomas L, Mohmand G, Zelynski A, Iredell J. Multiplex PCR for screening of integrons in bacterial lysates. J Microbiol Methods 2005;62:221–232.
23. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006;27:351–353.
24. Weniger T, Krawczyk J, Supply P, Niemann S, Harmsen D. MIRUVNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res 2010;38:W326–W331.
25. Allix-B_eguec C, Harmsen D, Weniger T, Supply P, Niemann S. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2008;46:2692–2699.
26. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005;43:4328–4335.
27. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005;43:4382–4390.
28. Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B, Esmaeili D et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol 2015;6:1146.
29. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007;13:807–815.
30. Najar Peerayeh S, Karmostaji A. Molecular identification of resistance determinants, integrons and genetic relatedness of extensively drug resistant Acinetobacter baumannii isolated From hospitals in Tehran, Iran. Jundishapur J Microbiol 2015;8:e27021.
31. Turton JF, Kaufmann ME, Gill MJ, Pike R, Scott PT et al. Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict. J Clin Microbiol 2006;44:2630–2634.
32. Wisplinghoff H, Hippler C, Bartual SG, Haefs C, Stefanik D et al. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. Clin Microbiol Infect 2008;14:708–715.
33. Zowawi HM, Sartor AL, Sidjabat HE, Balkhy HH, Walsh TR et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers. J Clin Microbiol 2015;53:896–903.
34. Azimi L, Talebi M, Khodaei F, Najafi M, Lari AR. Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis typing of carbapenemases producing Acinetobacter baumannii isolated from burn patients. Burns 2016;42:441–445.
35. Najar Peerayeh S, Karmostaji A. Molecular identification of resistance determinants, integrons and genetic relatedness of extensively drug resistant Acinetobacter baumannii isolated from hospitals in Tehran, Iran. Jundishapur J Microbiol 2015;8:e27021.
36. Schultz MB, Pham Thanh D, Tran do Hoan N, Wick RR, Ingle DJ et al. Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward. Microb Genom 2016;2: e000050.
37. Hauck Y, Soler C, Jault P, Mérens A, Gérome P et al. Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis. PLoS One 2012;7:e44597.
38. Johnson JK, Robinson GL, Zhao L, Harris AD, Stine OC et al. Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients. Diagn Microbiol Infect Dis 2016;86:345–350.